Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Phlebology ; 37(10): 701-708, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36154742

ABSTRACT

OBJECTIVE: To study the role of hyaluronic acid (HA) in polidocanol (POL) foam. METHODS: The dose-dependent effect of HA-POL on cultured human umbilical vein endothelial cells (HUVECs) as well as foam stability was evaluated by measuring optical density (OD) values and foam half-life time (FHT), respectively. An in vitro model was utilized for estimating the foam blood-displacement capacity by adopting maximum displacement distance (MDD) and displacement time. A comparison of foam viscosity was also carried out. RESULTS: The OD values of HUVECs treated with HA first increased and then decreased with the growing dosage of HA while cells treated with HA-POL died. Both FHT and displacement time were prolonged statistically with a gradually enhanced foam viscosity. As to MDD, there were no significant differences. CONCLUSIONS: HA was found to promote HUVECs proliferation slightly, but this was almost negligible when compared to the cell-killing capacity of 1% POL. The viscosity of POL foam was enhanced by HA indicating its positive correlation with both stability and displacement capacity of POL foam.


Subject(s)
Hyaluronic Acid , Sclerosing Solutions , Humans , Polidocanol/pharmacology , Hyaluronic Acid/pharmacology , Sclerotherapy , Endothelial Cells , Polyethylene Glycols/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...